HbA1c reductions plus weight loss and improved lipid profile with rimonabant in overweight/obese drug-naive type 2 diabetes:: the SERENADE trial in patients with BMI>27 kg/m2

被引：0

作者：

Rosenstock, J.

Hollander, P. A.

Iranmanesh, A.

机构：

[1] Dallas Diabet & Endocrine Ctr, Dallas, TX USA

[2] Baylor Univ, Med Ctr, Endocrinol Ctr, Dallas, TX USA

[3] Vet Adm Med Ctr, Endocrine Sect, Salem, MA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

835

引用

页码：S345 / S345

页数：1

HbA1c reductions plus weight loss and improved lipid profile with rimonabant in overweight/obese drug-naive type 2 diabetes:: the SERENADE trial in patients with BMI&gt;27 kg/m2